KDR and age-related macular degeneration: An alternative strategy to treat neovascular disease may be to preferentially target VEGF165 over other VEGF isoforms in circumstances where preserving VEGF120 signalling through VEGFR2 may be beneficial, especially for the long-term treatment of chronic diseases such as exudative AMD.